A Study of Baricitinib and Simvastatin in Healthy Participants

NCT01960140 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Baricitinib
DRUG: Simvastatin

Sponsor

Eli Lilly and Company